Share on

Global Nanomedicine Market Size, Share, Trends, COVID-19 Impact & Growth Analysis Report – Segmented By Product, Disease Type, Nano molecule Type and Region - Industry Forecast (2022 to 2027)

Published: January, 2022
ID: 6247
Pages: 180
Formats: report pdf report excel report power bi report ppt

Global Nanomedicine Market Size (2022 to 2027)

The size of the global nanomedicine market is estimated to grow USD 291.15 billion by 2027 from USD 159.43 billion in 2022, growing at a CAGR of 12.80% during the forecast period.

The application of various techniques and instruments of nanotechnology in the field of medicine is known as Nanomedicine. It involves using nanoscale materials to diagnose diseases, drug delivery, and other functions. Nanomedicine has the potential to revolutionize medicine in the future.


Increasing the acquisition of nanomedicine across various wide ranges of applications is one factor propelling the global nanomedicine market growth during the forecast period.

Growing government support and funds and the rising need for requirements for a few therapies are driving the market's market growth over the period. In addition, research and development related to the medical field in manufacturing novel drugs for the diseases influence the Nano-medicine market growth.

Furthermore, growing applications of nanomaterials such as nanocapsules and nanotubes in drug delivery systems, a growing number of cancer and cardiovascular diseases, increasing public and private investments in research activities in Nanomedicine, and advancements in the biodegradable nanoparticles are the significant factors propelling the growth of the Nanomedicine Market.


Unfavorable approval processes the possibility for unintended risks during therapies, and the high cost of treatment using nanomedicine is hindering the global nanomedicine market growth.

One of the significant challenges for the use of nanoparticles in medicine is to make the materials biocompatible. Applications of nanocapsules in drug delivery have shown excellent results in chemotherapy. Nanomedicine enables excellent precision in both diagnostics and therapeutics, which is not possible before. Pipeline products that are being developed to target cancerous tumors are expected to boost the Nanomedicine Market.

Covid-19 Impact on the global nanomedicine market:

Following the effect of COVID-19, governments and funds have increased their funding support for developing nano therapies for vaccines, diagnostic imaging, regenerative medicine, and drug delivery. Nanomedicines also have significant benefits for broader healthcare, influenced by the pandemic and long-term COVID impacts on cardiovascular, respiratory, neurological, and immunological disorders. Nanotech researchers and scientists are already working to enhance biomedical equipment like prostheses, create novel cancer treatments, and develop bone-healing medicines, among other innovations that have the potential to change global healthcare. Nanotech researchers discovered nanobodies that prevent COVID-19 and perhaps other coronaviruses from entering cells and mask designs that are cheaper and more effective at the nanoscale.

Nanotechnology was key in creating Pfizer and AstraZeneca vaccines and Innova Medical Group's 30-minute lateral-flow COVID testing, allowing for a quick worldwide response to the the trend, bringing the fairer and global distribution of healthcare, greater affordability, and preventive and early intervention healthcare, all ultimately improving the longevity of life."

COVID-19 exposed flaws in healthcare systems throughout the world, demonstrating the need for long-term, creative solutions to allow change and avoid future pandemics, with nanomedicine playing an ever-increasing role in this global healthcare transition."

The development of numerous vaccinations, the acceleration of genome-decoding technologies, the growth of nanomedicine, and the application of artificial intelligence to monitor infectious diseases and novel pathogens are all examples of this. More investment in long-term health tech financing will only accelerate this trend, resulting in more equitable and global healthcare distribution, more affordability, and preventative and early intervention healthcare, all of which will improve life expectancy."




Market Size Available

2021 to 2027

Base Year


Forecast Period

2022 to 2027

Segments Covered

By Product, Disease Type, Nano-molecule Type, and Region

Various Analyses Covered

Global, Regional & Country Level Analysis, Segment-Level Analysis, Drivers, Restraints, Opportunities, Challenges, PESTLE Analysis, Porter’s Five Forces Analysis, Competitive Landscape, Analyst Overview on Investment Opportunities

Regions Covered

North America, Europe, Asia Pacific, Latin America, Middle East, and Africa


This market research report on the global nanomedicine market has been segmented and sub-segmented based on the product, disease, nano-molecule, and region.

Nanomedicine Market – By Product

Based on product type, the drug delivery products segment is predicted to account for the largest share in the global nanomedicine market during the forecast period due to the incredible precision with which drugs are delivered to the target cells or tissues in the body.

Nanomedicine Market – By Disease Type

  • Cardiovascular Diseases    
  • Neurological Diseases        
  • Ophthalmological Diseases              
  • Infectious Diseases             
  • Immunological Diseases    
  • Orthopedic Disorders         
  • Oncological Diseases           
  • Others      

Based on disease type, the oncological diseases segment is projected to dominate the global nanomedicine market from 2021 to 2026. This is because most of the research conducted on Nanomedicine is focused on developing products for cancer treatment.

The cardiovascular diseases segment is considered to have quick progress with the highest CAGR of nearly 11.7% during the review period due to the appearance of chances such as demand for specific therapeutic Nano-vectors, Nano-structured stents, and implants for tissue regeneration accelerate the Nano-medicine market growth.

Nanomedicine Market– By Nano molecule Type:

  • Nanotubes
  • Nanoparticles
  • Nanodevices
  • Nanoshells
  • Others

Based on the Nano-molecule type analysis, the Nano-Particles segment is leading the Nano-medicine market growth. It is attributed to factors such as using these Nano-particles for active targeting by binding to ligands of a cell receptor, which is an essential tool for Nano-medicine and Nano-technology. These Nano-particles contain metal and metal oxide particles that influence market growth over the review period. Research and developments carried out for theranostics are expected to drive the market.

Nanomedicine Market– By Nano molecule Type:

  • North America
  • Europe
  • Asia-Pacific
  • Latin America
  • The Middle East and Africa

Geographically, the North American nanomedicine market is predicted to lead the global nanomedicine market during the forecast period due to the enormous investments in research in Nanomedicine from government organizations in the United States. The growth of this region is attributed due to the increasing existence of patented Nano-medicine products. The US is leading the Nano-medicine of the region due to considerable investments in market research from government organizations. In addition, developed healthcare infrastructure and high cancer occurrence, Nano-medicine is readily obtained in this region.

The nano-medicine market in the European region is considered to have produced profitable outcomes over the upcoming years, which owes to increasing burden and focus on advanced technologies in the market over the period. This region has got so many major companies in Nano-medicine, which results in high proliferation and sound knowledge among people. The UK is the leading country in the Nano-medicine market in this region. A wide range of Nano-medicine applications such as Nano-capsules and Nano-tubes in drug delivery systems may assist the UK market to grow high.

The Asia Pacific is expected to be the fastest-growing market due to the high incidences of cancer and cardiovascular diseases owing to a large geriatric population. A growing number of research grants and an increasing demand for life-threatening diseases are accelerating the market growth in the Asia Pacific. Older people's population growth in the Asia-Pacific region is one-factor surging market growth. China leads the market of this region due to the growing occurrence rate of cancer and cardiovascular diseases boosting the market growth. Japan is said to be the most attractive destination of the period.

The Latin American market is predicted to grow steadily over the analysis period. The growth of this region owes to increasing public and private organizations investments made on research activities in Nano-medicine, and advancements in biodegradable Nano-particles are the factors fueling the market growth. Brazil is accounted for having a significant share and leading the market of this region. Factors like developing the healthcare sector contribute to the growth of this country, and growing investments from the government are driving the growth in this region.

The Middle East & Africa has the least share in the global nanomedicine market over the forecast period. Factors like significant funds and investments made in clinical trials by the government and private sectors lead the market growth. In addition, the market growth is due to the high adoption rate in countries like Israel and Dubai. 


A few of the most dominating players in the global nanomedicine market profiled in this report are Johnson & Johnson, Merck & Co, Pfizer, Abbott Laboratories, GE Healthcare, Celgene Corporation, Nanosphere, Inc., Gilead Sciences, Hoffmann-La Roche, Nanospectra Biosciences, and Arrowhead Pharmaceuticals.


  • On March 05, 2019, Pfizer issued a license for AnTOIRx’s immune tolerance for an autoimmune illness, including rheumatoid arthritis, inflammatory bowel diseases, psoriasis, multiple sclerosis, and Type-1 diabetes. In addition, the technology is designed to bring immune tolerance to specific self-antigens in diabetes.

Please wait. . . . Your request is being processed

Related Reports

Access the study in MULTIPLE FORMATS
Purchase options starting from $ 2500

Didn’t find what you’re looking for?

Need something within your budget?


Call us on: +1 888 702 9696 (U.S Toll Free)

Write to us:

Click for Request Sample